Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Pneumococcal carriage and disease in adults in England 2011-2019: the importance of adults as a reservoir for pneumococcus in communities.

El Safadi D. et al, (2024), J Infect Dis

Genetic determinants of monocyte splicing are enriched for disease susceptibility loci including for COVID-19

Fairfax B. et al, (2024)

Relation between the Dantu blood group variant and bacteraemia in Kenyan children: a population-based case control study.

Kariuki SN. et al, (2024), J Infect Dis

Pathogen diversity and antimicrobial resistance transmission of Salmonella enterica serovars Typhi and Paratyphi A in Bangladesh, Nepal, and Malawi: a genomic epidemiological study.

Dyson ZA. et al, (2024), Lancet Microbe

Improved estimates of COVID-19 correlates of protection, antibody decay and vaccine efficacy waning: a joint modelling approach

Phillips DJ. et al, (2024)

Normalization of C1 Inhibitor in a Patient with Hereditary Angioedema.

Peters NE. et al, (2024), N Engl J Med, 391, 56 - 59

Effects of Two Early Parenting Programmes on Child Aggression and Risk for Violence in Brazil: a Randomised Controlled Trial.

Murray J. et al, (2024), Prev Sci

Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.

Feng S. et al, (2024), Health Technol Assess, 28, 1 - 109

Inflammation of the Nasal Mucosa is Associated with Susceptibility to Experimental Pneumococcal Challenge in Older Adults.

Urban BC. et al, (2024), Mucosal Immunol

Towards paratyphoid control: the vital role of the challenge model

McCann N. et al, (2024), The Lancet, 403, 2780 - 2781

Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse.

Flaxman A. et al, (2024), PLoS Pathog, 20

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine.

Bissett C. et al, (2024), NPJ Vaccines, 9

Spatial and temporal clustering of typhoid fever in an urban slum of Dhaka City: Implications for targeted typhoid vaccination.

Ahmmed F. et al, (2024), PLoS Negl Trop Dis, 18

Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging.

Jakobsen NA. et al, (2024), Cell Stem Cell

Translational Science at the Undergraduate Level: Awakening Talents to Overcome the Valley of Death – Viewpoint Showing a Success Case (Preprint)

Ferreira Jr RS. et al, (2024)

An evaluation of the national testing response during the COVID-19 pandemic in England: a multistage mixed-methods study protocol.

Naidoo R. et al, (2024), BMJ Open, 14

Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study.

Costa Clemens SA. et al, (2024), Lancet Microbe

COVID-19 mass testing in adult social care in England

Chen S. et al, (2024)

Examining the role of community champions to promote vaccine uptake in under-served communities in the United Kingdom: Lessons from the COVID-19 pandemic

Vanderslott S. et al, (2024), SSM - Qualitative Research in Health, 5

Strengthening life-course immunisation in migrant populations: access, equity, and inclusion

Knights F. et al, (2024), The Lancet Regional Health - Europe, 41

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?